Talphera (NASDAQ:TLPH) Announces Earnings Results, Hits Estimates

Talphera (NASDAQ:TLPH) issued its quarterly earnings data on Wednesday. The company reported ($0.06) earnings per share for the quarter, hitting the consensus estimate of ($0.06), FiscalAI reports.

Talphera Stock Down 4.8%

Shares of NASDAQ:TLPH traded down $0.07 during midday trading on Wednesday, hitting $1.40. The stock had a trading volume of 497,231 shares, compared to its average volume of 246,501. The company’s 50-day moving average price is $1.16 and its 200-day moving average price is $0.95. The company has a market capitalization of $72.66 million, a P/E ratio of -4.52 and a beta of 0.69. Talphera has a fifty-two week low of $0.40 and a fifty-two week high of $1.57.

Wall Street Analyst Weigh In

Several brokerages have recently commented on TLPH. HC Wainwright assumed coverage on shares of Talphera in a report on Friday, June 5th. They set a “buy” rating and a $3.00 target price on the stock. Wall Street Zen upgraded Talphera to a “hold” rating in a research note on Saturday. Zacks Research upgraded Talphera to a “hold” rating in a research note on Monday, June 8th. Westpark Capital assumed coverage on Talphera in a report on Thursday, April 30th. They issued a “buy” rating and a $3.00 price objective for the company. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Talphera in a research report on Friday, July 17th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Talphera currently has a consensus rating of “Hold” and a consensus price target of $3.00.

Institutional Trading of Talphera

Several large investors have recently made changes to their positions in the company. Cantor Fitzgerald L. P. bought a new position in shares of Talphera in the 4th quarter valued at $658,000. Renaissance Technologies LLC lifted its position in shares of Talphera by 412.6% during the 4th quarter. Renaissance Technologies LLC now owns 257,380 shares of the company’s stock worth $293,000 after buying an additional 207,166 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Talphera by 107.0% during the 4th quarter. Geode Capital Management LLC now owns 342,987 shares of the company’s stock worth $391,000 after buying an additional 177,294 shares during the last quarter. Nantahala Capital Management LLC lifted its position in shares of Talphera by 75.3% during the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock worth $3,120,000 after buying an additional 1,500,000 shares during the last quarter. Finally, Diadema Partners LP acquired a new stake in Talphera in the fourth quarter valued at about $156,000. Institutional investors and hedge funds own 37.67% of the company’s stock.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.